Related Experiment Video
Updated: Jun 14, 2025
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells
Ji Hong Kim1,2, Hyoseon Yu1, Ji Hye Kang1
1Department of Ophthalmology Hanyang University College of Medicine, Seoul, Republic of Korea.
Purpose:
This study aimed to evaluate the expression of microRNAs (miRNAs) and inflammasomes in diabetes-induced retinal cells and to determine their role in the pathogenesis of diabetic retinopathy (DR).
Methods:
To establish diabetes-induced cell models, ARPE-19 cells were treated with high glucose. The expression levels of five miRNAs (miR-185, miR-17, miR-20a, miR-15a, and miR-15b) were measured in high glucose-treated ARPE-19 cells using real-time quantitative polymerase chain reaction. Western blotting was performed to measure inflammasome expression in cellular models. miR-17 was selected as the target miRNA, and inflammasome expression was measured following the transfection of an miR-17 mimic into high glucose-treated ARPE-19 cells.
Results:
In high glucose-treated ARPE-19 cells, miRNA expression was substantially downregulated, whereas that of inflammasome components was significantly increased. Following the transfection of the miR-17 mimic into high glucose-treated ARPE-19 cells, the levels of inflammasome components were significantly decreased.
Conclusions:
This study investigated the relationship between miRNAs and inflammasomes in diabetes-induced cells using high glucose-treated ARPE-19 cells. These findings suggested that miR-17 suppresses inflammasomes, thereby reducing the subsequent inflammatory response and indicating that miRNAs and inflammasomes could serve as new therapeutic targets for DR.
Insights
MicroRNA-17 (miR-17) suppresses inflammasomes in diabetic retinopathy (DR) cells. This suggests that targeting miR-17 and inflammasomes may offer new therapeutic strategies for DR.
Area of Science:
- Ophthalmology
- Molecular Biology
- Cell Biology
Background:
- Diabetic retinopathy (DR) is a complication of diabetes affecting the eyes.
- MicroRNAs (miRNAs) and inflammasomes are implicated in DR pathogenesis.
- Understanding their interplay is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the expression of miRNAs and inflammasomes in diabetes-induced retinal cells.
- To determine the role of specific miRNAs, particularly miR-17, in regulating inflammasome activity.
- To explore the therapeutic potential of targeting miRNAs and inflammasomes for DR.
Main Methods:
- Established diabetes-induced retinal cell models using ARPE-19 cells treated with high glucose.
- Quantified miRNA expression using real-time quantitative polymerase chain reaction.
- Assessed inflammasome component expression via Western blotting.
- Investigated the effect of miR-17 mimic transfection on inflammasome levels.
Main Results:
- High glucose treatment led to downregulated miRNA expression and upregulated inflammasome components in ARPE-19 cells.
- Transfection of an miR-17 mimic significantly decreased inflammasome component levels.
- miR-17 demonstrated a suppressive effect on inflammasome activation.
Conclusions:
- miR-17 plays a protective role by inhibiting inflammasome-mediated inflammation in diabetic retinal cells.
- miRNAs and inflammasomes represent promising therapeutic targets for diabetic retinopathy.
- Further research into miRNA-based therapies could lead to novel treatments for DR.
